Literature DB >> 2859353

Cerebral ammonia metabolism in hyperammonemic rats.

A J Cooper, S N Mora, N F Cruz, A S Gelbard.   

Abstract

The short-term metabolic fate of blood-borne [13N]ammonia was determined in the brains of chronically (8- or 14-week portacaval-shunted rats) or acutely (urease-treated) hyperammonemic rats. Using a "freeze-blowing" technique it was shown that the overwhelming route for metabolism of blood-borne [13N]ammonia in normal, chronically hyperammonemic and acutely hyperammonemic rat brain was incorporation into glutamine (amide). However, the rate of turnover of [13N]ammonia to L-[amide-13N]glutamine was slower in the hyperammonemic rat brain than in the normal rat brain. The activities of several enzymes involved in cerebral ammonia and glutamate metabolism were also measured in the brains of 14-week portacaval-shunted rats. The rat brain appears to have little capacity to adapt to chronic hyperammonemia because there were no differences in activity compared with those of weight-matched controls for the following brain enzymes involved in glutamate/ammonia metabolism: glutamine synthetase, glutamate dehydrogenase, aspartate aminotransferase, glutamine transaminase, glutaminase, and glutamate decarboxylase. The present findings are discussed in the context of the known deleterious effects on the CNS of high ammonia levels in a variety of diseases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859353     DOI: 10.1111/j.1471-4159.1985.tb07159.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  42 in total

1.  [15N]alanine and [15N]ammonia metabolism in vivo.

Authors:  J L Cooper; A S Gelbard
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

Review 2.  Glutamatergic synaptic dysfunction in hyperammonemic syndromes.

Authors:  V L Rao; C R Murthy; R F Butterworth
Journal:  Metab Brain Dis       Date:  1992-03       Impact factor: 3.584

3.  Effects of simulated upper gastrointestinal hemorrhage on ammonia and related amino acids in blood and brain of chronic portacaval-shunted rats.

Authors:  S W Olde Damink; C H Dejong; N E Deutz; P B Soeters
Journal:  Metab Brain Dis       Date:  1997-06       Impact factor: 3.584

4.  Changes in glutamate-cycle enzyme mRNA levels in a rat model of hepatic encephalopathy.

Authors:  J W Thomas; C Banner; J Whitman; K D Mullen; E Freese
Journal:  Metab Brain Dis       Date:  1988-06       Impact factor: 3.584

5.  Neurochemical changes in cerebellum of goldfish exposed to various temperatures.

Authors:  A Poli; S Notari; M Virgili; E Fabbri; R Lucchi
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

6.  Encephalopathy in acute liver failure resulting from acetaminophen intoxication: new observations with potential therapy.

Authors:  Saul W Brusilow; Arthur J L Cooper
Journal:  Crit Care Med       Date:  2011-11       Impact factor: 7.598

7.  Detoxification of ammonia in mouse cortical GABAergic cell cultures increases neuronal oxidative metabolism and reveals an emerging role for release of glucose-derived alanine.

Authors:  Renata Leke; Lasse K Bak; Malene Anker; Torun M Melø; Michael Sørensen; Susanne Keiding; Hendrik Vilstrup; Peter Ott; Luis V Portela; Ursula Sonnewald; Arne Schousboe; Helle S Waagepetersen
Journal:  Neurotox Res       Date:  2010-05-18       Impact factor: 3.911

8.  15N n.m.r. measurement of the in vivo rate of glutamine synthesis and utilization at steady state in the brain of the hyperammonaemic rat.

Authors:  K Kanamori; B D Ross
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

Review 9.  Possible treatment of end-stage hyperammonemic encephalopathy by inhibition of glutamine synthetase.

Authors:  Arthur J L Cooper
Journal:  Metab Brain Dis       Date:  2012-10-13       Impact factor: 3.584

10.  Effect of portacaval anastomosis on glutamine synthetase activities in liver, brain, and skeletal muscle.

Authors:  G Girard; R F Butterworth
Journal:  Dig Dis Sci       Date:  1992-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.